The Center for AIDS Research at Emory University (CFAR) received a five-year, $10 million award from the National Institutes of Health (NIH) to further its work in decreasing HIV incidence, improving the well-being of infected individuals, training the next generation of researchers and clinical leaders, and ultimately finding a vaccine and cure for HIV.
Part of a national network of 20 leading research universities supported by the NIH, CFAR provides administrative and shared research support to enhance and coordinate HIV/AIDS research and supports development of early career investigators pursuing HIV/AIDS research. Centers for AIDS Research compete for funding renewal every five years and must demonstrate continued research growth, achievement in addressing the AIDS epidemic, and provide evidence of an impact in the fight against HIV/AIDS.
CFAR at Emory University is co-directed by Dr. Carlos del Rio, Hubert Professor and chair of the department of global health at the Rollins School of Public Health, Dr. James W. Curran, the James W. Curran Dean of the Rollins School of Public Health, and Dr. Eric Hunter, Georgia Research Alliance Eminent Scholar and professor of pathology and laboratory medicine at Emory University School of Medicine. For nearly two decades, CFAR has made significant strides in addressing the AIDS epidemic through clinical, basic, and prevention science.
“CFAR has been extremely successful in achieving its principal goal of first forming and then strategically expanding a university-wide, multidisciplinary community of scientists,” explains principal investigator, Dr. del Rio. “These renowned experts have led NIH-funded research resulting in globally recognized interventions that prevent new HIV transmissions and enhance the well-being of people living with, and at risk for, HIV.”
Having a CFAR at Emory has been critical to growing HIV/AIDS research funding at Emory. When Emory received its first funding in 1997, the university had $11.3 million in HIV/AIDS research funding and ranked #23 in the nation. Now, Emory ranks sixth in the country for HIV/AIDS NIH funding, with $63.8 million in HIV/AIDS research support. Additionally, 20 percent of Emory’s total NIH extramural funding is HIV/AIDS-related funding, contributing to a 63 percent growth in research funding since 2010.
“Over its 18-year history, the Center for AIDS Research at Emory has built an incredible research community and established a reputation as a center for excellence in HIV/AIDS research,” says Dr. Curran. “This funding further reinforces the significance of our research and ensures our ability to continue critical work in the field.”
“We are proud of our track record of cultivating and strengthening HIV/AIDS research for the past 18 years,” says Dr. Hunter. “Our world-class scientists are making a tremendous impact through their groundbreaking research and collaborative efforts. Through this continuation of NIH funding, we are able to move forward on our mission and intensify our efforts to reach our ultimate goals of developing an effective vaccine and finding a cure for HIV.”
Notable grants awarded to CFAR investigators this past funding cycle include:
Other significant accomplishments include: